Halifax Somatic Symptoms Disorder Trial

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Somatic Symptom and Related DisordersIntensive Short Term Dynamic Psychotherapy
Interventions
BEHAVIORAL

Intensive Short-Term Dynamic Psychotherapy

The ISTDP model is an emotion focused brief format of psychotherapy that helps the patients identify and address emotional factors that culminate into exacerbation and perpetuation of somatic symptoms. Treatment will be provided according to manualized recommendations. The emphasis is on awareness of emotions and how they affect the person's behavioral patterns and somatic presentation. The research protocol calls for the treatment duration to be initially agreed at 8 weeks and then reviewed. Treatment should be delivered as a maximum 20-session time-limited format. The first session is an extended 2-3 hour appointment; then sessions are planned to occur on a weekly basis lasting 60 minutes in duration. Treatment progress is reviewed, specifically at sessions 4 and 8 to clarify the goal and objectives of further sessions. Patients are informed of the maximum treatment length. Termination in fewer sessions is based upon agreement between therapist and patient.

BEHAVIORAL

Medical Care As Usual (MCAU)

This Medical Care As Usual (MCAU) was selected to control for both the role of emergency department care and family doctors care, as well as the passage of time and the natural emergence and reduction in symptoms before further intervention. Participants allocated to this group are advised that care will continue to be provided to them by the ED and they will be contacted with an appointment to see a therapist in 8 weeks should they so wish. They are advised to contact their family physician for routine care where necessary

Trial Locations (1)

B3H 2E2

Capital District Health Authority, Halifax

All Listed Sponsors
lead

Nova Scotia Health Authority

OTHER

NCT02076867 - Halifax Somatic Symptoms Disorder Trial | Biotech Hunter | Biotech Hunter